Manifestations of X-linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers
(2024) In European Journal of Neurology- Abstract
Background and purpose: Pyruvate dehydrogenase complex deficiency is in up to 90% caused by pathogenic variants in the X-linked PDHA1 gene. We aimed to investigate female relatives of index patients with PDHA1-related disease to (i) describe the prevalence of female PDHA1 carriers, (ii) determine whether they had symptoms and signs, and (iii) delineate the associated phenotype. Methods: In a national population-based study, we identified 37 patients with pathogenic variants in PDHA1. Sanger sequencing for the presence of the pathogenic variant was performed in their mothers and female relatives. The identified female carriers were clinically assessed, and their medical records were reviewed. Results: The proportion carrying a de novo... (More)
Background and purpose: Pyruvate dehydrogenase complex deficiency is in up to 90% caused by pathogenic variants in the X-linked PDHA1 gene. We aimed to investigate female relatives of index patients with PDHA1-related disease to (i) describe the prevalence of female PDHA1 carriers, (ii) determine whether they had symptoms and signs, and (iii) delineate the associated phenotype. Methods: In a national population-based study, we identified 37 patients with pathogenic variants in PDHA1. Sanger sequencing for the presence of the pathogenic variant was performed in their mothers and female relatives. The identified female carriers were clinically assessed, and their medical records were reviewed. Results: The proportion carrying a de novo variant was 86%. We identified seven female PDHA1 carriers from five families. Five of them exhibited clinical features of the disease and were previously undiagnosed; all had signs of peripheral axonal neuropathy, four presented with strokelike episodes including two with Leigh-like lesions, and three had facial stigmata. Conclusions: PDHA1-related disease is underrecognized in heterozygous female carriers. Peripheral axonal neuropathy, strokelike and Leigh-like changes, and facial dysmorphism should raise suspicion of the disorder. Genetic analysis and clinical examination of potential female carriers are important for genetic counseling and have implications for treatment.
(Less)
- author
- Savvidou, Antri ; Sofou, Kalliopi ; Eklund, Erik A. LU ; Aronsson, Johan and Darin, Niklas
- organization
- publishing date
- 2024
- type
- Contribution to journal
- publication status
- epub
- subject
- keywords
- mitochondrial, PDHA1, PDHc deficiency, peripheral axonal neuropathy, stroke
- in
- European Journal of Neurology
- publisher
- Wiley-Blackwell
- external identifiers
-
- pmid:38497591
- scopus:85188439983
- ISSN
- 1351-5101
- DOI
- 10.1111/ene.16283
- language
- English
- LU publication?
- yes
- id
- 21873c02-e399-4a4b-ad35-e245e6f4a0cc
- date added to LUP
- 2024-04-12 10:04:09
- date last changed
- 2024-04-26 11:59:53
@article{21873c02-e399-4a4b-ad35-e245e6f4a0cc,
abstract = {{<p>Background and purpose: Pyruvate dehydrogenase complex deficiency is in up to 90% caused by pathogenic variants in the X-linked PDHA1 gene. We aimed to investigate female relatives of index patients with PDHA1-related disease to (i) describe the prevalence of female PDHA1 carriers, (ii) determine whether they had symptoms and signs, and (iii) delineate the associated phenotype. Methods: In a national population-based study, we identified 37 patients with pathogenic variants in PDHA1. Sanger sequencing for the presence of the pathogenic variant was performed in their mothers and female relatives. The identified female carriers were clinically assessed, and their medical records were reviewed. Results: The proportion carrying a de novo variant was 86%. We identified seven female PDHA1 carriers from five families. Five of them exhibited clinical features of the disease and were previously undiagnosed; all had signs of peripheral axonal neuropathy, four presented with strokelike episodes including two with Leigh-like lesions, and three had facial stigmata. Conclusions: PDHA1-related disease is underrecognized in heterozygous female carriers. Peripheral axonal neuropathy, strokelike and Leigh-like changes, and facial dysmorphism should raise suspicion of the disorder. Genetic analysis and clinical examination of potential female carriers are important for genetic counseling and have implications for treatment.</p>}},
author = {{Savvidou, Antri and Sofou, Kalliopi and Eklund, Erik A. and Aronsson, Johan and Darin, Niklas}},
issn = {{1351-5101}},
keywords = {{mitochondrial; PDHA1; PDHc deficiency; peripheral axonal neuropathy; stroke}},
language = {{eng}},
publisher = {{Wiley-Blackwell}},
series = {{European Journal of Neurology}},
title = {{Manifestations of X-linked pyruvate dehydrogenase complex deficiency in female PDHA1 carriers}},
url = {{http://dx.doi.org/10.1111/ene.16283}},
doi = {{10.1111/ene.16283}},
year = {{2024}},
}